Teleman Dan Benjamin
SEC CIK 2122500 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NSRX | Nasus Pharma Ltd | CEO, Dir | 163.5K | $61.8K | — | 3 | 2026-03-31 | 2026-06-17 |
Most active insiders at NSRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Teleman Dan Benjamin | CEO, Dir | $61.8K | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 07:12 | 2026-06-17 | NSRX | Nasus Pharma Ltd | Teleman Dan Benjamin | CEO, Dir | P - Purchase | $3.10 | +6,550 | 163.5K | +4% | +$20.3K | |
| 2026-04-22 21:44 | 2026-04-22 | NSRX | Nasus Pharma Ltd | Teleman Dan Benjamin | CEO, Dir | P - Purchase | $3.76 | +2,900 | 157.0K | +2% | +$10.9K | |
| 2026-04-01 07:31 | 2026-03-31 | NSRX | Nasus Pharma Ltd | Teleman Dan Benjamin | CEO, Dir | P - Purchase | $2.04 | +15.0K | 21.2K | +240% | +$30.6K |
Purchase Sale Sale after option exercise All abbreviations